Similar associations between nuclear HSF1 and drug resistance against doxorubicin, paclitaxel, carboplatin, and bortezomib have been previously shown in multiple types of cancer cells, such as breast cancer, hepatocellular carcinoma, melanoma, and multiple myeloma cells [10,35,36,37]. This evidence concerns the gene HSF1 and AL amyloidosis.